No Data
No Data
Yifang Biotech: Yifang Biotech Report for the First Quarter of 2025
Yifang Biotech\'s 2025 First Quarter Report
Summary of Yifang Biotech\'s 2024 Annual Report
Yifang Biotech 2024 Annual Report
Are Investors Undervaluing InventisBio Co., Limited (SHSE:688382) By 38%?
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.